![Michael Yeadon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael Yeadon is the founder of Ziarco Pharma Ltd. founded in 2012.
He previously held positions as President & Chief Executive Officer at Ziarco Group Ltd., Director at Antegrin Therapeutics LLC and Indalo Therapeutics, Inc., Chief Scientific Officer at Apellis Pharmaceuticals, Inc., Chief Scientific Officer & Vice President at Pfizer (St. Louis), and Senior Principal Scientist at Wellcome Research Laboratories.
Yeadon earned an undergraduate degree in 1985 and a doctorate in 1988 from the University of Surrey.
Anciens postes connus de Michael Yeadon
| Sociétés | Poste | Fin |
|---|---|---|
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics targeting skin inflammatory and allergic diseases | Directeur Général | 30/03/2016 |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Directeur/Membre du Conseil | - |
Antegrin Therapeutics LLC
 Antegrin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops novel therapies for fibrotic diseases | Directeur/Membre du Conseil | - |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Directeur Technique/Scientifique/R&D | - |
| APELLIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Michael Yeadon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Apellis Pharmaceuticals, Inc.
 Apellis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics and drug delivery technologies to address chronic inflammatory diseases | Health Technology |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
Wellcome Research Laboratories | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Provides therapeutics targeting inflammatory and allergic diseases | Health Technology |
Antegrin Therapeutics LLC
Antegrin Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops novel therapies for fibrotic diseases | Health Technology |
Ziarco Group Ltd.
Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics targeting skin inflammatory and allergic diseases | Health Technology |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Health Technology |
